When we stratified BC specimens using PAM50, a 50-gene signature that classifies BC into five molecular subtypes, basal-like tumors expressed more CSF2, CXCL10, and CCL2 than luminal A/B tumors according to TCGA (Fig. 5a), a finding supported by previous studies40,41. The gene discussed is CXCL10; the disease is breast cancer.